U.S. HHS Reports Progress on Import Safety Action Plan, Rx Groups To Further Collaborate
This article was originally published in PharmAsia News
Executive Summary
An import "safety summit" being convened July 9 features a multi-stakeholder medical products panel moderated by U.S. FDA Commissioner Andrew von Eschenbach
You may also be interested in...
Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Von Eschenbach spoke with PharmAsia News about international regulatory collaboration and his vision for the future of the agency.
Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Von Eschenbach spoke with PharmAsia News about international regulatory collaboration and his vision for the future of the agency.
Import Safety Pilot Casts Global Inspection Net For Drug Manufacturers
The U.S. is launching a pilot program with Australia and the European Union to "spread our inspection net wider" for drug manufacturing facilities, according to Health and Human Services Secretary Michael Leavitt